Bionano Genomics Moves Into Speculative Buy Territory 2021-05-19T16:39:48-04:00May 19th, 2021| share this article! Bionano Genomics recently reported healthy Saphyr Systems sales in the first quarter. As a result, BNGO stock gained over 20%. Is it a buy? Read More share this article! Related Posts Jefferies Just Raised Its Price Target on Palantir (PLTR) Stock May 3rd, 2024 Intesa CEO cautious on share buybacks, upbeat on fees May 3rd, 2024 China Market Update: Hong Kong Growth Stocks Climb The Great Wall Of Underweight, Week In Review May 3rd, 2024 Trump Admits Gag Order Doesn’t Stop Him From Testifying—After Judge Corrects Him May 3rd, 2024
